Podcasts about hypertrophic cardiomyopathy center

Tales from the Heart host Lisa Salberg is joined by Matt Martinez, MD, Director of Sports Cardiology and Hypertrophic Cardiomyopathy Center at Morristown Medical Center and Angeline Owens, MD, the medical director of The Center for Inherited Cardiovascular Disease at Penn Medicine. This conversation was recorded April 19, 2024.

On Total Information, Tom Ackerman and Meghan Lynch discuss a frightening incident involving NBA superstar LeBron James' son, Bronny James. The 18-year-old freshman on the USC basketball team suffered a cardiac arrest during a workout, prompting an urgent rush to the hospital. Dr. Keith Mankowitz , Director of the Hypertrophic Cardiomyopathy Center at St. Luke's Hospital, sheds light on the difference between cardiac arrest and heart attacks and explains the potential triggers and recovery process. The conversation also addresses concerns about COVID vaccines and overexertion in athletes.    © EFE

"There is a high global prevalence of hostile work environment in cardiology, including discrimination, emotional harassment, and sexual harassment.” Sharma G. et al. JACC 2021. Dr Naidu was at the beginning of his career when, having experienced micro-aggression, his chairman shared an insight that still shapes the way he thinks about addressing professional jealousy and bullying: “Don't let people bring you down, you just keep working and lift them up.” In this week's Parallax, Dr Ankur Kalra is joined by Dr Srihari S Naidu, Director of Cath Labs and Hypertrophic Cardiomyopathy Center at the Westchester Medical Center and President Elect of NY ACC, for an honest conversation on a challenging topic within the cardiology community. Cardiology, a highly competitive field, still generates the sense that power is equal to strength. In this insightful and practical episode, Hari revisits his own experiences both as a leader and as a trainee, navigating complex situations. What can you do as a target when being bullied? How can hostile environment, cliques be best addressed? Ankur asks what skills are needed to help mitigate the emotional impact of intimidation. Hari elaborates on what it means to belong to a team, and how can leaders at a local level work for an inclusive community, a better cardiology for all. Questions and comments can be sent to “podcast@radciffe-group.com” and may be answered by Ankur in the next episode. Guest @SrihariNaiduMD, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO. Brought to you by Edwards: www.edwardstavr.com

Cardiac imaging is important not only for diagnosing hypertrophic cardiomyopathy (HCM) but also in making decisions about treatment and risk of future events. Dr. Milind Desai, Director of the Hypertrophic Cardiomyopathy Center, takes you through the types of testing and what they show. Tests include basic echocardiogram, specialized echo testing, MRI and transesophageal echo. Patients require testing at baseline to diagnose HCM and monitoring over time – it is your friend for life!

Hypertrophic Cardiomyopathy Center specialists have recently published three papers related to a wide range of patients with HCM, including the elderly, pediatric and general population. Dr. Milind Desai, Director of the HCM Center reviews the implications for diagnosis, management and risk stratification based on the results of these papers.

Hypertrophic Cardiomyopathy (HCM) involves more than septal thickness. Dr. Nicholas Smedira, Surgical Director of Cleveland Clinic’s Hypertrophic Cardiomyopathy Center describes what happens when a patient has hypertrophic cardiomyopathy. A team approach is used to understand the anatomy and cause of obstruction. Many surgical approaches are available to individualize the care for the HCM patient to address the obstruction or treat the heart when a patient has HCM without obstruction.

Sammy Gilbreath was still a young man when he was told he had a ticking time bomb in his chest, and there was nothing he could do about it — except go home and live like each day was his last.   Hypertrophic Cardiomyopathy Center and Research Institute at Tufts Medical Center https://www.tuftsmedicalcenter.org/patient-care-services/departments-and-services/hypertrophic-cardiomyopathy-center/overview   Support our sponsors: The Office of Evangelism at the Alabama Baptist State Board of Missions — visit https://evangelizeal.org to find events, resources for evangelism strategies and apologetics training.   This podcast is a product of TAB Media.

In this episode of Tales from the Heart, Lisa talks to Dr. Martin Maron, the Director of the Hypertrophic Cardiomyopathy Center at Tufts Medical Center and Associate Professor at Tufts University School of Medicine. His specialties include cardiac imaging, hypertrophic cardiomyopathy, and cardiac magnetic resonance imaging. Lisa and Dr. Maron talk about the how HCM treatment has improved over the years and how it will evolve in the future.

In this episode of Tales from the Heart, Lisa talks to Dr. Martin Maron, the Director of the Hypertrophic Cardiomyopathy Center at Tufts Medical Center and Associate Professor at Tufts University School of Medicine. His specialties include cardiac imaging, hypertrophic cardiomyopathy, and cardiac magnetic resonance imaging. In this episode Dr. Maron talks about cardiac imaging in HCM, the history of HCM treatment and diagnosis,  the purpose and usefulness of an echocardiogram, contrast echocardiogram, normal values for wall thickness, obstruction, heart murmur, cardiac MRI, and more. 

In this episode of Tales from the Heart, Lisa talks to Dr. Martin Maron, the Director of the Hypertrophic Cardiomyopathy Center at Tufts Medical Center and Associate Professor at Tufts University School of Medicine. His specialties include cardiac imagining, hypertrophic cardiomyopathy, and cardiac magnetic resonance imaging. In this episode Dr. Maron talks with Lisa about why HCM is so poorly misunderstood. Lisa also reads questions from the live Facebook chat for Dr. Maron to answer.   This episode was record on 09/11/2020 and Lisa and Dr. Maron take a few minutes to pay tribute to the lives that were lost in the tragic terrorist attacks on the World Trade Center on 09/11/2001.

Dr. Steve Nissen talks with cardiologist Dr. Milind Desai and surgeon Dr. Nick Smedira, Directors of the Hypertrophic Cardiomyopathy Center, about current treatment options, such as medications and surgical therapy, what we have learned from years of experience with HCM at Cleveland Clinic, and a new innovative medication that is being researched that may reduce the need for – or delay surgery.

Hypertrophic Cardiomyopathy (HCM) in the majority of cases causes restriction of blood flow in the outflow tract of the heart caused by systolic anterior motion (SAM) of the mitral valve. Dr. Steve Nissen talks with cardiologist Dr. Milind Desai and surgeon Dr. Nick Smedira, Directors of the Hypertrophic Cardiomyopathy Center, about current treatment options, such as medications and surgical therapy, what we have learned from years of experience with HCM at Cleveland Clinic, and a new innovative medication that is being researched that may reduce the need for – or delay surgery.

After a webchat, Dr. Harry Lever, Director of the Cleveland Clinic’s Hypertrophic Cardiomyopathy Center, reviewed common questions that patients asked about diagnostic testing, symptoms, when a patient needs surgery for HCM (myectomy and/or mitral valve repair), and genetic testing.

In this episode I visit with Dr Richard Bach, the director of the Hypertrophic Cardiomyopathy Center at Washington University. We talk about everything from diagnosis, risk of exercise, medical management, indications for myectomy and alcohol ablations. Link to transcript on MedPage Today

Dr. Barry J. Maron, Director of the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute at Abbott-Northwestern Hospital looks explains how to risk stratify hypertrophic cardiomyopathy (HCM) patients and describes the role of the implantable cardioverter defibrillator in HCM patients.

Host: Michael Greenberg, MD Hypertrophic cardiomyopathy (HCM) is the leading cause of sudden death in young athletes. Joining host Dr. Michael Greenberg to discuss HCM is Dr. Martin Maron, director of the Hypertrophic Cardiomyopathy Center and co-director of cardiac MRI and CT at Tufts Medical Center. As an imaging specialist, Dr. Maron utilizes cardiac MRI and cardiac CT for the evaluation and treatment of patients. Discussing all aspects of HCM, Dr. Maron and Dr. Greenberg address this most common of all genetic cardiac diseases (occurring in 1/500 individuals), invasive and non-invasive treatment, and implications for HCM patients involved in sports.

Host: Michael Greenberg, MD Hypertrophic cardiomyopathy (HCM) is the leading cause of sudden death in young athletes. Joining host Dr. Michael Greenberg to discuss HCM is Dr. Martin Maron, director of the Hypertrophic Cardiomyopathy Center and co-director of cardiac MRI and CT at Tufts Medical Center. As an imaging specialist, Dr. Maron utilizes cardiac MRI and cardiac CT for the evaluation and treatment of patients. Discussing all aspects of HCM, Dr. Maron and Dr. Greenberg address this most common of all genetic cardiac diseases (occurring in 1/500 individuals), invasive and non-invasive treatment, and implications for HCM patients involved in sports.

Host: Michael Greenberg, MD Hypertrophic cardiomyopathy (HCM) is the leading cause of sudden death in young athletes. Joining host Dr. Michael Greenberg to discuss HCM is Dr. Martin Maron, director of the Hypertrophic Cardiomyopathy Center and co-director of cardiac MRI and CT at Tufts Medical Center. As an imaging specialist, Dr. Maron utilizes cardiac MRI and cardiac CT for the evaluation and treatment of patients. Discussing all aspects of HCM, Dr. Maron and Dr. Greenberg address this most common of all genetic cardiac diseases (occurring in 1/500 individuals), invasive and non-invasive treatment, and implications for HCM patients involved in sports.

Guest: Barry Maron, MD Host: Matthew J. Sorrentino, MD, FACC, FASH What is the risk of sudden death for patients with hypertrophic cardiomyopathy? Dr. Barry Maron, Director of the Hypertrophic Cardiomyopathy Center in Minneapolis, will discuss the risk of sudden death and the use of defibrillators in these high risk patients.